Aerie Looks Modestly Undervalued Despite High Cash Burn
Summary: Aerie has 2 marketed products and decent pipeline after a recent acquisition.Aerie unfortunately still has...
Tag: AERI
Reassessing Aerie Pharmaceuticals
Summary: Today, we revisit ocular concern Aerie Pharmaceuticals.The company has struggled as a newly minted 'Tier 3', with...
Aerie Pharmaceuticals: Guidance Is Unachievable After Failed Drug Launches; 70%+ Downside
Summary: Sell-side estimates for this quarter's revenue are too high and have begun to be cut.The guidance of 110m in...
The Verdict On Aerie Pharmaceuticals
Summary: We revisit Aerie Pharmaceuticals. The stock has had a wild ride, getting crushed in the back half of 2018 and...
Updating My Aerie Pharmaceuticals Short
Summary: Aerie Pharmaceuticals was one of my two favorite shorts as recently as August 2018.Since then, earnings data and...